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The ORNATE India project is an interdisciplinary, multifaceted United Kingdom (UK)–India collaborative 
study aimed to build research capacity and capability in India and the UK to tackle the burden of 
diabetes-related visual impairment. For 51 months (October 2017–December 2021), this project built 
collaboration between six institutions in the UK and seven in India, including the Government of 
Kerala. Diabetic retinopathy (DR) screening models were evaluated in the public system in Kerala. An 
epidemiological study of diabetes and its complications was conducted through 20 centers across India 
covering 10 states and one union territory. The statistical analysis is not yet complete. In the UK, risk models 
for	diabetes	and	its	complications	and	artificial	 intelligence‑aided	tools	are	being	developed.	These	were	
complemented by joint studies on various aspects of diabetes between collaborators in the UK and India. 
This interdisciplinary team enabled increased capability in several workstreams, resulting in an increased 
number	of	publications,	development	of	cost‑effective	risk	models,	algorithms	for	risk‑based	screening,	and	
policy for state-wide implementation of sustainable DR screening and treatment programs in primary care 
in	Kerala.	The	increase	in	research	capacity	included	multiple	disciplines	from	field	workers,	administrators,	
project managers, project leads, screeners, graders, optometrists, nurses, general practitioners, and research 
associates in various disciplines. Cross-fertilization of these disciplines enabled the development of several 
collaborations	external	to	this	project.	This	collaborative	project	has	made	a	significant	impact	on	research	
capacity development in both India and the UK.
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The Global Challenges Research Fund (GCRF) was set up by the 
UK Government in 2015 to address complex global development 
challenges and support collaborative research that will improve 
the	economic	prosperity,	welfare,	and	quality	of	life	of	people	
in low and middle-income countries (LMICs). The ORNATE 
India project, funded by GCRF and United Kingdom Research 
and Innovation (UKRI) in 2017, is a UK–India collaboration to 
build research capacity and capability to tackle the burden of 
diabetes-related visual impairment.[1] Six institutions in the UK 
and seven in India collaborated on this project, including the 
Government of Kerala.
Locally led health research in LMICs is critical for overcoming 
global	health	challenges.	Sufficient	research	capacity	in	LMICs	
is essential to build a local evidence-based healthcare policy and 
improve the health of the population.[2] The UK Department 
of	Health	defines	 research	 capacity	 building	 as	 “a	process	
of individual and institutional development which leads to 
higher levels of skills and greater ability to perform useful 
research.”[3] Central to capacity building at the individual 
level is the training and mentoring of the investigators to ask 
the	 locally	 relevant	 research	questions,	design	and	conduct	
research, create or adapt research tools that address the research 
questions,	 and	 build	 collaborations	with	 and	 outside	 the	
institutions, both nationally and internationally. An additional 
requirement	is	to	train	the	investigators	to	work	with	the	policy	
and program implementers for both bedside and community 
practice. Capacity building is vital at an institutional level to 
create new knowledge, enhance career opportunities for young 
investigators, and infrastructure development. A good research 
environment	also	needs	the	required	processes	and	people	for	
seamless grants management personnel, data management, 
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financial	management,	procurement	policies,	and	appropriate	
research governance.
The Enhancing Support for Strengthening Capacity and 
Effectiveness of National Capacity Efforts (ESSENCE) on 
Health Research initiative released a good practice document 
for capacity strengthening in LMICs with the following seven 
guiding principles:[4]
1. Network, collaborate, communicate, and share experiences
2. Understand the local context and accurately evaluate 
existing research capacity
3. Ensure local ownership and secure active support
4. Build in monitoring, evaluation, and learning from the start
5. Establish robust research governance and support 
structures,	and	promote	effective	leadership




diverse approaches to build research capacity and capability, 
both in the UK and India. It broadly covered a multistate 
epidemiological investigation in India to study the prevalence of 
pre-diabetes, diabetes, and diabetic retinopathy (DR), diagnostic 
accuracy studies of laboratory and nonlaboratory tools to detect 
diabetes and its complications, process evaluation, and health 
economic assessment of a new DR care pathway in the public 
health	system.	The	 innovative	approaches	 included	artificial	
intelligence to grade retinal images, circulating biomarkers to 
predict DR and sensor to detect biomarkers in blood, predictive 
risk modeling studies, and developing research networks to 
support global translation. In addition, the project focused 
on developing population scientists and statisticians, health 
economics, public health, and computer scientists to use various 
UK	and	India	datasets	to	answer	research	questions,	especially	
risk models that can be applied globally.
Here we describe the capacity-building activities for 
two studies, namely the SMART-India study and the 
Nayanamritham study, undertaken in India to address the 
increasing burden of blindness due to DR so that it can be used 
as an example for translation to other LMICs.
Methods
ORNATE India embedded the abovementioned principles 
of the ESSENCE framework[4] to guide capacity building 
in this collaborative project between India and the UK. 
The	 governance	 structure	 was	 organized	 as	 an	 equal	
partnership, with joint leadership and joint development 
of study protocols, standard operating procedures, and 
publications. The local investigators from India were engaged 
in the design and conduct of all aspects of the studies done 
in India. A formal research collaboration agreement was 
signed by all collaborating institutions in the UK and India; 
it included the roles and responsibilities of each collaborator 
and an agreement for sharing any intellectual property. 
A set of measurable, feasible, and comprehensive indicators 
was developed to capture the complexities and evaluate the 
research capacity-building activities.
SMART-India study
The SMART-India (Translating research into clinical and 
community practice: a multicenter Statistical and economical 
Modelling	of	risk‑based	strAtified	and	peRsonalized	screening	
for complications of diabetes in India) study is a cross-sectional 
community-based house-to-house study across 20 sites in 
India to provide data on the prevalence of diabetes, DR, and 
other complications of diabetes, as well as develop practical 
and	affordable	models	 to	 (a)	diagnose	people	with	diabetes	
and pre-diabetes and (b) identify those at risk of diabetes 
complications so that these models can be applied to the 
population	in	LMICs	where	laboratory	tests	are	unaffordable.[5] 
The study sample covered urban and rural populations in 
different	geographical	regions	(North,	South,	East,	and	West)	
and included 10 states and one union territory. Fig. 1 shows the 
20 sites that participated in the SMART-India study.
Protocol. The study protocol was developed after a 
brainstorming session in Chennai, India, between UK and India 
co‑applicants	 and	collaborators.	 Study	 sites	were	 confirmed	
for each region, and the principal investigator (PI) of each 
study site was trained to provide local leadership. The group 
also developed all the study documents, including the survey 
questionnaire.	A	project	manager	was	appointed	to	coordinate	
the study. The study was approved by the Indian Council of 
Medical	Research	(ICMR)/Ministry	of	Health	and	Family	Welfare	
Screening	Committee	and	Institutional	Ethics	Committees	of	all	
the 20 participating institutions. The study obtained informed 
written	consent	from	all	participants	and	adhered	to	the	tenets	of	
the Declaration of Helsinki on human research. The methodology 
for the SMART-India study has already been published.[5]
Field workers conducted house-to-house surveys. They 
were trained in the SMART-India study protocol, filling 
and	filing	 (cloud‑based)	 of	participant	 information	 sheets,	
data collection and entry into the cloud-based database, 
point-of-care blood tests (random blood glucose, HbA1c, 
and lipids), urine microalbuminuria, blood pressure, 
anthropometric measurements, vision test, and obtaining good 
quality	retinal	images	using	a	nonmydriatic	hand‑held‑based	
retinal camera (Zeiss Visuscout 100™). A teleophthalmology 
system was set up whereby the images captured by each 
fieldworker	were	uploaded	to	a	cloud‑based	database.






Anonymized retinal images were graded by retinal graders 
optometrists and ophthalmologists (primary graders) at the 
local clinical center, as well as transferred to four central 
reading centers, where grading was done by a second 
ophthalmologist (secondary grader ). A senior retinal 
consultant arbitrated in case of any discrepancies between 




Center administrators were appointed, one for each study 
site, and were trained in the study protocol and study database 
at a 2-day workshop held in Chennai, India. They were 
responsible	for	setting	up	and	maintaining	the	study	master	
file	and	the	study	logistics,	such	as	a	seamless	supply	of	point	
of care kits to the 20 sites, ensuring completion of retinal image 
grading, informing participants of the outcome of the retinal 
grading, and coordinating with the participants who were 
referred	for	sight‑threatening	DR	(STDR)	and	other	findings	
requiring	 referral.	 In	 addition	 to	 the	 initial	 training,	 three	
additional online training sessions were provided for the center 
administrators by the data manager and project manager.
The Nayanamritham study
The Nayanamritham study aimed to implement a 
pilot DR care pathway in the public system in the 
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Thiruvananthapuram district in Kerala. It involved screening 
for DR in 16 family health centers (FHCs) (primary care), 
management of referred patients at four secondary care 
centers (district hospitals), and one tertiary care center 
at the Regional Institute of Ophthalmology (RIO).[7] The 
study protocol was developed by the Health Secretary in 
Kerala, noncommunicable disease (NCD) lead in Directorate 
of Health Services, other health and medical education 
service providers, technical and eHealth teams, local 
authorities,	and	the	GCRF/UKRI‑funded	co‑applicants	from	
the UK. A project manager was appointed to manage the 
program under the supervision of the NCD lead. Capacity 
and capability building was initiated to implement DR 
screening in the FHCs, grading images at the reading 
center at RIO, and treatment for DR at secondary care. The 
Nayanamritham study was approved by the Indian Council 
of Medical Research (ICMR, Ref:2018-0551) and the RIO, 
Thiruvananthapuram.	The	study	obtained	informed	written	
consent from all participants and adhered to the tenets of 
the Declaration of Helsinki on human research.
Project management: The collaborative team developed 
study protocols; patient information sheets and consent forms; 
study	data	 collection	 forms;	 qualitative	 interview	 training,	
monitoring, and evaluation; and a monthly reporting system. 
Smartphone-based retinal cameras (Remidio Innovative 
Solutions, Bengaluru, India) were procured for the 16 FHCs and 
RIO. The general physicians and nurses at the FHCs received 
training in diabetes and management of DR, developed by the 
University	of	East	London;	the	university	certified	the	successful	
candidates. Generalist nurses at the FHCs were trained to obtain 
good	quality	retinal	images.	Further	training	was	imparted	to	
the	nurses	who	could	not	capture	good	quality	retinal	images.
Data-entry operators were employed (initially, the nurses 
were considered but changed to ease their burden) and trained 
on the different aspects of data collection and entry. The 
collected data included demographics, education, personal 
lifestyle (smoking, alcohol, and physical activity), family history, 
blood pressure, body mass index, and waist circumference.
Referral System: Patients	identified	with	STDR	were	referred	
to	four	district	hospitals.	Laser	equipment	was	purchased	for	
each hospital, and the ophthalmologists were trained in laser 
surgery at RIO. More complex cases of DR were treated at the 
tertiary care center (RIO). All these events were duly captured.
Accredited social health activists (ASHAs) were trained in 
groups of 50–100 on diabetic eye disease and the need to treat 
vision-threatening complications to increase public awareness 
and encourage patients to participate in the DR screening 
Figure 1: The 20 sites across India that participated in the SMART India study. Reproduced from S. Sivaprasad et al., Protocol on a multicentre 
statistical and economic modelling study of risk-based stratified and personalised screening for diabetes and its complications in India (SMART 
India), BMJ Open 2020;10:e039657.[5] Permitted under https://creativecommons.org/licenses/by/4.0/
November 2021 Conroy, et al.: Building research capacity to tackle diabetic retinopathy-related in India 3061
program, in addition to promoting primary prevention of 
diabetes.
A comprehensive monitoring evaluation and learning 
framework with key outcome indicators were used to evaluate 
the	effectiveness	of	the	research	capacity‑building	activities	in	
the SMART-India and Nayanamritham studies.
Results
SMART-India study
The capacity and capability building under this study included 
procurement of hand-held retinal cameras, point-of-care kits and 
equipment,	the	establishment	of	retina	image	reading‑grading	
centers, and training of healthcare personnel [Table 1]. 
Preliminary results show that 57,808 participants were recruited 
to	the	study,	of	which	22%	had	diabetes,	based	on	HbA1c	≥	6.5%.	
The retinal images of 12,832 participants with diabetes were sent 
for grading, of which 324 individuals (2.5%) were referred for 
STDR treatment. The study data analysis is ongoing.
A	field	worker	capturing	a	retinal	image	from	a	participant	
in the SMART-India study using hand-held smartphone-based 
nonmydriatic retinal cameras (Zeiss Visuscout 100™) [Fig. 2].
Training field workers to conduct telephone surveys and 
conduct qualitative research
Recruitment to SMART-India study was discontinued in March 
2020	due	to	the	COVID‑19	pandemic,	and	a	questionnaire‑based	
survey to evaluate the impact of COVID-19 lockdown on 
health and provision of healthcare services on participants in 
SMART-India was undertaken.[8] The collaborators developed the 
questionnaire	and	translated	it	into	seven	languages	to	address	
the	non‑English‑speaking	population.	A	total	of	41	fieldworkers	
from the 20 centers in the SMART-India study received four 
online	training	sessions	in	the	survey	questionnaire,	obtaining	
consent from participants and data entry into the cloud-based 
database explicitly developed for this study.
In	 addition,	 a	 qualitative	 study	was	 undertaken	 to	
understand the barriers and enablers to access treatment 
for STDR for those identified with this condition in the 
SMART-India study. Ten field workers involved in the 
SMART‑India	 study	undertook	 a	 five‑day	 online	 training	
in	qualitative	 research	 techniques	 in	 collaboration	with	 an	
NGO (Samarth). Additional online training was provided 
with the project manager and data manager in the UK for 
conducting in-depth interviews with patients who accessed 
and did not access treatment for STDR, as well as with health 
care professionals providing the treatments in eye hospitals.
India retinal disease study group
The ophthalmologists from across 20 clinical sites in the 
SMART-India study set up the India Retinal Disease Study 
Group	 to	 drive	 high‑quality	 research	 to	 answer	 relevant	
questions	related	to	diabetes	and	its	complications	 in	India.	
This group is working together with more clinical researchers 
to analyze several retrospective and longitudinal studies 
in diabetes and diabetic-related eye diseases. The model 
was driven mainly by regular virtual meetings discussing 
the research methodology, study protocols, and assistance 
in	 scientific	writing,	 leading	 to	 several	publications	 led	by	
researchers in India. Other collaborations and partnerships 
include the Public Health Foundation of India (PHFI) and the 
All India Ophthalmological Society (AIOS).
Table 1: Capacity/Capability building for the SMART‑India study
SMART‑India study set‑up
Study protocol developed collaboratively
Ethics approval obtained from ethics review committees at each institution and ICMR
Project manager appointed
The study-based questionnaire developed and tested
Cloud-based database for data entry and uploading of retinal images developed and tested
Patient information sheets and patient informed consent forms prepared and translated into local languages
Master file prepared for each site
Hand‑held retinal cameras (Zeiss Visuscout 100™) purchased and distributed to 20 sites for DR screening 
Point‑of‑care kits (e.g., HbA1c and lipids) and equipment (e.g., blood pressure monitors) bought and distributed to 20 sites
Twenty tablets for data entry bought and distributed to field workers
Set up of 4 main reading centers to grade retinal images
Staff training for SMART‑India study Numbers trained
Principal investigators trained in the study protocol and database application 24
Field workers trained in the study protocol and database application 70
Center administrators trained in the study protocol and database application 42
Primary graders, secondary graders, and arbitration graders trained to access retinal 
images and report findings using the database application
35
Figure 2: A field worker capturing a retinal image from a participant 
in the SMART-India study using a hand-held smartphone-based 
nonmydriatic retinal cameras (Zeiss Visuscout 100™)
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Table 2: Capability/Capacity building for the Nayanamritham study
DR care pathway set‑up
DR care pathway developed by local leaders and UK collaborators
Project manager appointed
Study protocol developed collaboratively
Ethics approval obtained 
Development of patient information sheets and consent forms, translated into Malayalam
IT infrastructure developed to integrate DR screening at FHCs into eHealth and transfer retinal images from primary care to reading center 
for grading
Retinal cameras purchased for each FHC (16) and tertiary center (1)
Laser equipment for the treatment of DR in secondary care purchased (4)
The reading center established to grade retinal images
Training of staff involved in the DR care pathway implementation Numbers trained
Optometrists trained and certified 20
General physicians in primary care trained in diabetes and DR management 38
Nurses in primary care trained in diabetes and DR management and retinal imaging following dilation 70
Data entry operators trained to collect patient data and enter into eHealth 20
Ophthalmologists in secondary care trained to do laser surgery 5
Doctors in FHCs trained on principles of laser application 50
ASHAs trained to increase public awareness of diabetes and its complications 411
A two-day research capacity building webinar was 
organized by the collaborators in India, with 16 speakers 
worldwide, exploring research funding for early career 
researchers, types of research needing funding, different 
funding bodies in India and internationally, and how to write 
a	grant	proposal.	The	webinars	were	 attended	by	over	 200	
researchers, both basic and clinical, many of which are applying 
for	grants	for	the	first	time.
Nayanamritham study
The capacity and capability building in this pilot study 
included	the	development	of	IT	infrastructure,	with	significant	
contribution from the Government of Kerala, the establishment 
of	Reading	Grading	Center	at	the	RIO	and	certification	of	retinal	
image	graders	(https://drscreening.org/test‑and‑training),	and	
training of a number of medical personnel at various levels and 
for a variety of activities of DR care [Table 2]. Joint training 
sessions	between	the	camera	manufacturers	and	project	staff	
enabled group learning at each FHC. Cascading of training 
from	the	first	group	of	trained	staff	to	other	staff	that	joined	
the project or participated in DR screening helped to ensure 
the sustainability of the screening at the FHCs.
During this pilot study, 5,307 people with diabetes, 
registered in the NCD registers at the 16 FHCs, were screened 
for DR; of these, 1,662 (31.3%) were referred to secondary 
centers either due to ungradable images or for treatment 
of STDR. The clinical and cost-effectiveness and process 
evaluation of the DR care pathway is ongoing.
Based on the successful implementation of this pilot DR 
care pathway in the public health system, the Government 
of Kerala is upscaling the screening to referral and treatment 
process across other districts in Kerala.
Discussion
India, home to over one-sixth of the world’s population, is in 
the midst of a diabetes epidemic. The International Diabetes 
Federation (IDF) has estimated that 77 million adults (20–
79 years) had diabetes in 2019, and this number is predicted 
to increase to 101 million in 2030 and 134.23 million in 2045. 
In addition, an estimated further 43.9 million people have 
undiagnosed diabetes.[9,10]
Although cataract and refractive errors are the leading causes 
of visual impairment in LMIC, the diabetes epidemic is a global 
risk due to associated increased numbers of DR-associated visual 
impairment. Sight-threatening DR, which includes proliferative 
diabetic	retinopathy	and/or	diabetic	macular	edema,	is	a	common	
cause of visual impairment in people with diabetes. Timely 
detection and treatment of DR can prevent blindness, but many 
people with this condition are not diagnosed early enough to be 
treated	effectively.	Population‑based	studies	in	India	over	the	
last two decades report a prevalence of DR at approximately 18% 
in urban and 10% in rural areas.[11] However, there is a lack of 
contemporary data on DR prevalence in many regions in India.
To prepare for this emerging problem of visual impairment 
due to diabetes, India needs a systematic approach from 
screening	to	treatment,	an	effective	public‑private	partnership,	
and a conducive public health policy for noncommunicable 
diseases,	including	diabetes.	There	are	significant	challenges	in	
establishing a systematic screening program for DR with regular 
recall in India. First, the numbers of people with diabetes are too 
large to replicate successful DR screening programs from other 
smaller countries. To sustain DR screening programs, diabetes 
registers must be established to invite people with diabetes for 
regular screening. These registers must origin at primary care and 
diabetes centers. The current model of opportunistic screening 
in India is not sustainable; thus, new models of DR screening 
must be developed. In addition, new risk-based triage models 
are	required	 to	urgently	 identify	 the	high‑risk	people	 for	DR	
screening so that rates of blindness can be decreased relatively 
faster while systematic screening processes are being established.
Both the SMART-India study and the Nayanamritham study 
attempted	to	address	some	of	these	needs.	By	building	research	
capacity	and	capability,	it	was	possible	to	collect	high‑quality	
data in the SMART-India study, pertinent to understand the 
current prevalence of diabetes, DR, and other diabetes-related 
complications in 11 states and one union territory. We also 
evaluated the tests that could be used for holistic screening 
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for diabetes and its complications. In addition, a deep learning 
algorithm for DR detection using retinal images taken by the 
field	workers	using	a	low‑cost	nonmydriatic	hand‑held	retinal	
camera is being developed.[12] This and the use of low-cost 
hand‑held	retinal	cameras	can	significantly	expand	community	
screening for DR in LMICs.[13,14]
Kerala reports a high prevalence of diabetes—up to 1 in 5 
adults aged 30 years or older may have the condition.[15] The 
Government of Kerala has prioritized screening for end-organ 
damage in people with diabetes within the public health system, 
but DR screening and management remains a challenge. Those 
with sight loss self-referred to tertiary care centers, resulting in 
over-burdened services with patients with irreversible visual 
loss, a situation seen in most LMICs. By partnering with the 
Government of Kerala, steps were developed to adapt the DR 
screening and treatment programs used in high-income countries 
to Kerala - the Nayanamritham study. This pilot study shows that 
building capacity and capability makes it possible to implement a 
DR care pathway in the public health system in Kerala, spanning 
primary, secondary, and tertiary care. Economic evaluation 
and outcome data from the study created evidence, which can 
inform	policy	on	situating	screening	of	DR	in	primary	care	setting	
and treating in secondary hospitals instead of tertiary centers. 
Integrating DR screening within the existing public system, 
without	significant	 investment	except	 for	 training	and	capital	
costs, ensured a smooth transition from research to a scalable 
and sustainable state-wide program, which has the potential to 
be	replicated	in	other	Indian	states	and	LMIC	settings.
Given	the	complexity	and	the	number	of	challenges	required	
to establish a DR care pathway for people with diabetes in India, 
it is necessary to integrate research into each of the components 
of	the	pathway.	In	these	projects,	the	learnings	from	the	scientific	
process and system of DR care used in the UK were used to 
guide the investigators in India. One of the important outcomes 
was the interdisciplinary collaboration and partnership with the 
Government of Kerala, who took ownership of the project to 
integrate	the	research	findings	into	policy	development.
Challenges
Our	efforts	 to	build	 research	capacity	 to	design	and	execute	




difficult	 to	establish	a	 link	between	screening	at	 the	primary	
level	and	 treatment	at	 the	secondary/tertiary	 level.	ORNATE	
India	brought	together	many	investigators	for	the	first	time	to	
jointly design and conduct the SMART-India study across 20 
clinical sites and to form the Indian Retinal Disease study group 
for collaborative research to analyze retrospective multicentric 
data on diabetic-related eye disease to inform clinical standards 
there.	The	daily	workload	was	high	for	most	staff	members;	thus,	
training had to be limited to the times that they were available.
Due to the unexpected COVID-19 pandemic and the ensuing 
lockdown, the SMART-India study was halted. However, 
prompt	online	data	cleansing,	resolution	of	queries	by	the	field	
workers, prompt completion of retinal image grading by the 
graders across the 20 sites, and remote monitoring through 




facilitate uptake of screening but hinder access to treatment. 
The scale-up of the DR pathway to the entire state is also an 
opportunity for the Government of Kerala to structure an 
implementation research proposal around it, using the capacity 
built by the Nayanamithram project.
Conclusion
The sustainability and scalability of research in diabetes and 
DR due to the ORNATE India project will be the lasting legacy 
of	this	grant	and	will	be	measured	by	the	increase	in	scientific	
outputs,	successful	grants,	and	new	partnerships	in	this	field.	The	
UK–India collaboration has created an enabling environment for 
the local researchers to set goals and tailor study protocols to 
local needs and opportunities. In addition to focusing on capacity 
building, ORNATE India has resulted in fruitful collaborative 
partnerships built on mutual trust and shared decision-making.
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